Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FASTENAL CO Director's Dealing 2025

Jul 18, 2025

29988_dirs_2025-07-18_d98c93bc-be2f-4f39-8caf-1ea8d84d4870.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FASTENAL CO (FAST)
CIK: 0000815556
Period of Report: 2025-07-17

Reporting Person: Lisowski Sheryl Ann (Interim CFO and EVP-CAO/Treas.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-17 Common Stock M 12000 $24 Acquired 22192 Direct
2025-07-17 Common Stock S 12000 $45.22 Disposed 10192 Direct
2025-07-17 Common Stock M 5052 $19 Acquired 15244 Direct
2025-07-17 Common Stock S 5052 $45.2028 Disposed 10192 Direct
2025-07-17 Common Stock M 4000 $24 Acquired 14192 Direct
2025-07-17 Common Stock S 4000 $45.2069 Disposed 10192 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-07-17 Employee Stock Option (Right to Buy) $24 M 12000 Disposed 2032-12-31 Common Stock (12000) Direct
2025-07-17 Employee Stock Option (Right to Buy) $19 M 5052 Disposed 2027-12-31 Common Stock (5052) Direct
2025-07-17 Employee Stock Option (Right to Buy) $24 M 4000 Disposed 2030-12-31 Common Stock (4000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4195 Indirect

Footnotes

F1: On May 21, 2025, the Common Stock of Fastenal Company spilt 2-for-1 and the amounts reported have been adjusted to reflect the stock split.

F2: Shares attributed to reporting person's account within issuer's 401(K) Plan.

F3: The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date.

F4: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years after the grant date and the remainder vesting and becoming exercisable proportionately (20%, 20% and 20%) each year thereafter.